Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practicing in specific cardiology domains.
Professor Sechtem said: “Another new aspect is that the diagnostic algorithm is based on pre-test probability, in line with the 2010 UK National Institute for Health and Clinical Excellence (NICE) guidelines on chest pain of recent onset. The estimation of pre-test probability is based on the latest data measuring the prevalence of coronary artery stenosis in a current large cohort of male and female patients of various ages with various clinical presentations.”
Professor Sechtem said: “The approach to patients with functional coronary disease, i.e. coronary vasospasm or microvascular disease, has been redefined. The definition of this group by clinical and non-invasive evaluation has become more important than in 2006 as more patients, especially females, undergo invasive coronary angiography because of stable angina and are then found to have no epicardial stenosis.”
He added: “Before there is any discussion about revascularization, patients should receive optimal medical therapy. The decision on the type of revascularization should then be based on a discussion between the surgeon and the cardiologist in the heart team. Moreover, revascularization should only be considered in patients with evidence of regional ischemia or a pathological fractional flow reserve (FFR).”
He concluded: “We hope that overuse of coronary CT angiography will be discouraged by the clear definition of a patient group at the lower range of intermediate pretest probabilities in whom this technique may be helpful for excluding stenoses.”
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved